Home
NSE: OXYGENTAPHARMA
ISIN
NSE: OXYGENTAPHARMA
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) |
---|---|
27 Jan 2025 | 76.95 |
24 Jan 2025 | 80.97 |
23 Jan 2025 | 79.11 |
22 Jan 2025 | 80.95 |
21 Jan 2025 | 78.8 |
20 Jan 2025 | 76.16 |
17 Jan 2025 | 77.69 |
16 Jan 2025 | 78 |
15 Jan 2025 | 76.74 |
14 Jan 2025 | 79.98 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Oxygenta Pharmaceutical Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Net Profit of Oxygenta Pharmaceutical Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as agai
Read more
16 Aug 24
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 August 20
Read more
12 Aug 24
Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the company will be
Read more
18 Sept 24
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 November
Read more
11 Nov 24